Summary
A critical and highly-detailed 500-page analysis that brings the products, research and performance of 86 leading companies under the spotlight.
Orthopaedics continues to be one of leading medical device sectors, consistently providing good levels of return to developers and investors, and real benefits for healthcare professionals.
The drivers for this success are many:
The traditional hip and knee replacement market which continues to be the bedrock of sector, with the market expanding in line with an increasingly elderly population.
Improvements in biomaterials are seeing product value being added and better patient outcomes.
New areas, such as spinal disc replacement, will see the sector further enhanced.
For analysts, investors and company executives, the ability to readily assess the companies involved, the research they are pursuing, products being developed, strategic collaborations and performance/funding is key to understanding this market.
That is why this management report is the essential reference work for everyone in the field. In over 500 information-packed pages, Orthopaedic Companies Analysis 2005 (published August 2005) analyses 86 companies from multinationals to specialist organisations. Every type of orthopaedic, prosthetic and fixation device is covered.
|
